News Bayer gets €3bn from Apollo for contraceptives unit stake Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.
News NICE backs NHS use of non-invasive endometriosis tests Women with endometriosis in England could be offered simple non-invasive tests for diagnosis of their condition, rather than a surgical procedure.
News NICE guidance calls for quicker diagnosis of PMOS Women with polyendocrine metabolic ovarian syndrome (PMOS) should be diagnosed sooner and be offered an annual review, according to new NICE guidance.
Patients Is women’s health reaching an inflection point? A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.
News SCOTUS retains telemedicine access to abortion pill The Supreme Court of the US has ruled that abortion pill mifepristone can continue to be prescribed remotely and delivered by mail-order – for now.
News Danco fights back after US court curbs abortion pill access In another setback for abortion care in the US, an appeals court has issued an order restricting the distribution of mifepristone through the mail.
News GSK gets second cancer drug approval from Nuvalent buy The FDA has cleared GSK's ALK inhibitor Nelkarmi for a form of lung cancer, the second product from its $10.6bn acquisition of Nuvalent.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.